AB-FUBINACA
Effect Profile
Describes the acute effect. This profile does not influence the OpenMind Score.
No effect profiles yet. Describe the acute effect without changing the long-term score.
Please log in to add effect details
Log inDescription
Arguably the most common synthetic cannabinoid, AB-FUBINACA was originally developed by Pfizer as an analgesic, but has since abandoned for medical use. It has since found a following in the RC community, however it's extremely high potency and inclusion in synthetic blends makes it dangerous, and it has killed in overdose. Exercise caution.
Dosage
Oral
| Light | Common | Strong | Heavy |
|---|---|---|---|
| 0.25-0.5 mg | 0.5-1.5 mg | 1.5-3 mg | 3-3 mg+ |
Smoked
| Light | Common | Strong | Heavy |
|---|---|---|---|
| 0.25-0.5 mg | 0.5-1.5 mg | 1.5-3 mg | 3-3 mg+ |
Duration
Oral
Detection Times
| Method | Detection Window |
|---|---|
| Urine | 3–7 days |
Note: Synthetic cannabinoid. NOT detected by standard THC immunoassay. Requires specific synthetic cannabinoid testing panel.
Community Experiences
Share a single experience — does not affect the OpenMind Score.
Comments
Please log in to comment
Log inEverything in OpenMind
Track your use, check combinations and find safer use tips – even offline.
No comments yet.